Impact Of Reclassifying Noninvasive Follicular Variant Of Papillary Thyroid Carcinoma On The Risk Of Malignancy In The Bethesda System For Reporting Thyroid Cytopathology.
William C Faquin, L. Q. Wong, Amir H Afrogheh, Syed Zulfiqar Ali, Justin A. Bishop, Massimo Bongiovanni, Marc P Pusztaszeri, Christopher J. VandenBussche, Jolanta Gourmaud, Louis J. Vaickus, Zubair W Baloch
Published 2016 · Medicine
Download PDFAnalyze on Scholarcy
BACKGROUND Recent discussions have focused on redefining noninvasive follicular variant of papillary thyroid carcinoma (NI-FVPTC) as a neoplasm rather than a carcinoma. This study assesses the potential impact of such a reclassification on the implied risk of malignancy (ROM) for the diagnostic categories of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). METHODS The study consisted of consecutive fine-needle aspiration biopsy (FNAB) cases collected between January 1, 2013 and June 30, 2014 from 5 academic institutions. Demographic information, cytology diagnoses, and surgical pathology follow-up were recorded. The ROM was calculated with and without NI-FVPTC and was presented as a range: all cases (ie, overall risk of malignancy [OROM]) versus those with surgical follow-up only. RESULTS The FNAB cohort consisted of 6943 thyroid nodules representing 5179 women and 1409 men with an average age of 54 years (range, 9-94 years). The combined average ROM and OROM for the diagnostic categories of TBSRTC were as follows: nondiagnostic, 4.4% to 25.3%; benign, 0.9% to 9.3%; atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS), 12.1% to 31.2%; follicular neoplasm (FN), 21.8% to 33.2%; suspicious for malignancy (SM), 62.1% to 82.6%; and malignant, 75.9% to 99.1%. The impact of reclassifying NI-FVPTC on the ROM and OROM was most pronounced and statistically significant in the 3 indeterminate categories: the AUS/FLUS category had a decrease of 5.2% to 13.6%, the FN category had a decrease of 9.9% to 15.1%, and the SM category had a decrease of 17.6% to 23.4% (P < .05), whereas the benign and malignant categories had decreases of 0.3% to 3.5% and 2.5% to 3.3%, respectfully. The trend of the effect on the ROM and OROM was similar for all 5 institutions. CONCLUSIONS The results from this multi-institutional cohort indicate that the reclassification of NI-FVPTC will have a significant impact on the ROM for the 3 indeterminate categories of TBSRTC.
This paper references
Encapsulated follicular variant of papillary thyroid carcinoma.
Zubair Baloch (2002)
"Colloid-rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: cytologic, histologic, and molecular basis for considering an alternate view.
N Paul Ohori (2013)
Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal.
Zhiyan Liu (2011)
The triage efficacy of fine needle aspiration biopsy for follicular variant of papillary thyroid carcinoma using the Bethesda reporting guidelines.
Elizabeth M. Kurian (2012)
Encapsulated Well-differentiated Follicular-patterned Thyroid Carcinomas Do Not Play a Significant Role in the Fatality Rates From Thyroid Carcinoma
Simonetta Piana (2010)
Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.
Ronald A. Ghossein (2006)
Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations.
William C Faquin (2010)
Indications for thyroid FNA and pre-FNA requirements: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference.
Edmund S Cibas (2008)
Atypia of undetermined significance and nondiagnostic rates in The Bethesda System for Reporting Thyroid Cytopathology are inversely related.
Paul A VanderLaan (2012)
The Impact of Diagnostic Changes on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Selected High-Resource Countries.
Salvatore Vaccarella (2015)
New Strategies in Diagnosing Cancer in Thyroid Nodules: Impact of Molecular Markers
Yuri E Nikiforov (2013)
Encapsulated follicular variant of papillary thyroid carcinoma.
Jennifer Leigh Hunt (2002)
The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.
Kyle C. Strickland (2015)
Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities.
Sachin Gupta (2012)
Encapsulated classic and follicular variants of papillary thyroid carcinoma: comparative clinicopathologic study.
Zubair W Baloch (2010)
Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.
Vickie Y. Jo (2010)
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
Yuri E Nikiforov (2014)
Diminishing diagnosis of follicular thyroid carcinoma.
Kristen J. Otto (2010)
Thyroid Cytopathology: Bethesda and Beyond
Syed Zulfiqar Ali (2010)
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S. Cooper (2009)
The Bethesda System for Reporting Thyroid Cytopathology.
Edmund S Cibas (2009)
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
Erik K. Alexander (2012)
The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology.
Daniel S. Duick (2012)
The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
Massimo Bongiovanni (2012)
Molecular testing for oncogenic gene mutations in thyroid lesions: a case-control validation study in 413 postsurgical specimens.
Thomas J. Giordano (2014)
The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation
Zubair W Baloch (2008)
Evidence for overestimation of the prevalence of malignancy in indeterminate thyroid nodules classified as Bethesda category III.
Mazen E. Iskandar (2015)
Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long-term Outcome in 2444 Consecutively Treated Patients
Ian D. Hay (2002)
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
N Paul Ohori (2013)
Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).
M. Rivera (2009)
Molecular diagnostics of thyroid tumors.
Yuri E Nikiforov (2011)
Thyroid Bethesda reporting category, 'suspicious for papillary thyroid carcinoma', pitfalls and clues to optimize the use of this category.
Aparna N. Mahajan (2013)
Observer Variation of Encapsulated Follicular Lesions of the Thyroid Gland
Mitsuyoshi Hirokawa (2002)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER.
Louise Davies (2015)
This paper is referenced by
The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International Panel
Marc P Pusztaszeri (2016)
Follicular Variant of Papillary Thyroid
Gilbert H. Daniels (2016)
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features is Rare: A Population Based Study of Incidence
Rasmus H Reinke (2019)
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a problematic entity
Klaudia Zajkowska (2020)
Follicular Variant of Papillary Thyroid Carcinoma: Hybrid or Mixture?
Gilbert H. Daniels (2016)
Cytologic and clinical features of NIFTP: Can we diagnose based on preoperative fine-needle aspiration.
Lei Yan (2019)
American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with
Bryan R. Haugen (2017)
Pathologic Diagnosis of Thyroid Cancer
Xiaoyin “Sara” Jiang (2017)
Decision Making in Indeterminate Thyroid Nodules and the Role of Molecular Testing.
Janeil M Mitchell (2019)
Impact of the Reclassification of “Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma” to “Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features” on the Bethesda System for Reporting Thyroid Cytopathology: A Large Academic Institution’s Experience
Ryan P. Lau (2017)
Comprehensive analysis for diagnosis of preoperative non-invasive follicular thyroid neoplasm with papillary-like nuclear features
Hye Seung Lee (2019)
Citopatología de tiroides. Punción por aguja fina
Carmen Franco (2018)
Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
Francesca Maletta (2016)
Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management
Jocelyn B. Chandler (2017)
Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis.
Huy Gia Vuong (2019)
The impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) on the diagnosis of thyroid nodules.
Marc P Pusztaszeri (2019)
Pre‐operative features of non‐invasive follicular thyroid neoplasms with papillary‐like nuclear features: An analysis of their cytological, Gene Expression Classifier and sonographic findings
Sharon J Song (2017)
Noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP)
Haijun Zhou (2018)
Recent Developments in the Pathology of Thyroid Cancer.
David Nigel Poller (2017)
The influence of the noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP) resection diagnosis on the false‐positive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria
N Paul Ohori (2017)
Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
Soo Yeon Hahn (2017)
Underestimated risk of cancer in solitary thyroid nodules ≥3 cm reported as benign
Sohail Bakkar (2017)
Thyroid Nodule Diagnostic Markers in the Face of the New NIFTP Category: Time for a Reset?
Zeyad T Sahli (2017)
Clinical Diagnostic Evaluation of Thyroid Nodules.
Carolyn Maxwell (2019)
Correspondence of cytological and histopathological diagnoses in diagnostic category V of the Bethesda system: "suspicious for malignancy".
Agata Stanek-Widera (2016)
Noninvasive follicular thyroid neoplasm with papillary nuclear characteristics: Clinicopathologic features and follow-up
Oscar Brunás (2018)
Refining the criteria for an atypical thyroid aspirate.
Jeffrey F Krane (2019)
Head and Neck: Thyroid
Paul A VanderLaan (2014)
Combining Total Variation Regularization with Window-Based Time Delay Estimation in Ultrasound Elastography
Mehdi Mirzaei (2019)
Pathology of the Thyroid: A Review
Virginia A. Livolsi (2019)
Standardized terminology systems in cytopathology
Kaitlin E Sundling (2019)
Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Report of an Institutional Experience with 86 Cases
Marc P Pusztaszeri (2017)See more